Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Spinal Restoration (Austin, TX), a clinical stage biotechnology company focused on the treatment of discogenic chronic low back pain, closed a $5M Series C financing. Participants include Austin Ventures, Santé Ventures, MB Venture Partners and Comerica Bank. ___________ Collective IP the Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer […]

Small Bone Innovations (Morrisville, PA) a commercial-stage a small bone and joint device company focused on arthroplasty, fixation, trauma and biologic solutions, closed a $35M Series D, bringing the total round financing to $108M. Participants include Goldman Sachs, Khazanah Nasional Berhad, Malaysian Technology Development Corp., The Family Office of Bahrain, Trevi Health Ventures, NGN Capital, […]

Small Bone Innovations (Morrisville, PA) a commercial-stage a small bone and joint device company focused on arthroplasty, fixation, trauma and biologic solutions, closed a $73M Series D financing. Participants include 3i Group, NGN Capital, Trevi Health Ventures, Viscogliosi Brothers, Vollin Holdings, and The Family Office Co.

Orthoscan (Scottsdale, AZ) developer of medical device imaging products with a focus on orthopaedics, closed a $7.5M Series B financing. Participants include River Cities Capital Funds, Aphelion Capital and California Technology Ventures.

Histogenics (Waltham, MA) early-stage cartilage regeneration company developing products for joint repair, closed a $9M Series B financing. Participants include Boston Millennia Partners, Foundation Medical Partners, Altima Partners, Stryker Corporation and Inflection Point Partners.

Cayenne Medical (Scottsdale, AZ) developer of soft tissue reconstruction and repair segment for orthopedic applications, closed a $15M Series C financing. Participants include Investor Growth Capital and Split Rock Partners.

Omeros (Seattle, WA) a biopharmaceutical company focused on improving joint function following arthroscopic surgeries raised $63M in a Series E financing. Investors included Aravis Ventures, Arch Venture Partners, American Financial Group, Grosvenor Funds, Novartis Venture Fund, Southern Cross Capital, Stanley Medical Research Institute, and Trevi Health Ventures.

  

to top of page...